Human Immunodeficiency Virus (HIV): References

1. Moses S, Plummer FA, Bradley JE, Ndinya–Achola JO, Nagelkerke NJ, Ronald AR. The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis. 1994;21:201–210.

2. Malita FM, Karelis AD, Toma E, Rabasa–Lhoret R. Effects of different types of exercise on body composition and fat distribution in HIV–infected patients: a brief review. Can J Appl Physiol. 2005;30:233–245.

3. Nixon S, O'Brien K, Glazier RH, Tynan AM. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2005;(2):CD001796.

4. Pereira DB, Antoni MH, Danielson A, et al. Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med. 2003;65:427–434.

5. Pereira DB, Antoni MH, Danielson A, et al. Stress as a predictor of symptomatic genital herpes virus recurrence in women with human immunodeficiency virus. J Psychosom Res. 2003;54:237–244.

6. Ironson G, Weiss S, Lydston D, et al. The impact of improved self–efficacy on HIV viral load and distress in culturally diverse women living with AIDS: the SMART/EST Women's Project. AIDS Care. 2005;17:222–236.

7. Antoni MH, Cruess DG, Klimas N, et al. Stress management and immune system reconstitution in symptomatic HIV–infected gay men over time: effects on transitional naive T cells (CD4(+)CD45RA(+)CD29(+). Am J Psychiatry. 2002;159:143–145.

8. Weber R, Christen L, Christen S, et al. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antivir Ther. 2004;9:85–95.

9. Antoni MH. Stress management effects on psychological, endocrinological, and immune functioning in men with HIV infection: empirical support for a psychoneuroimmunological model. Stress. 2003;6:173–188.

10. Crenn P, Rakotoanbinina B, Raynaud JJ, Thuillier F, Messing B, Melchior JC. Hyperphagia contributes to the normal body composition and protein–energy balance in HIV–infected asymptomatic men. J Nutr. 2004;134:2301–2306.

11. Williams SB, Bartsch G, Muurahainen N, Collins G, Raghavan SS, Wheeler D. Protein intake is positively associated with body cell mass in weight–stable HIV–infected men. J Nutr. 2003;133:1143–1146.

12. Coyne–Meyers K, Trombley LE. A review of nutrition in human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Nutr Clin Pract. 2004;19:340–355.

13. Rathmacher JA, Nissen S, Panton L, et al. Supplementation with a combination of beta–hydroxy–beta–methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. JPEN J Parenter Enteral Nutr. 2004;28:65–75.

14. Schon T, Elias D, Moges F, et al. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. Eur Respir J. 2003;21:483–488.

15. Clark RH, Feleke G, Din M, et al. Nutritional treatment for acquired immunodeficiency virus–associated wasting using beta–hydroxy beta–methylbutyrate, glutamine, and arginine: a randomized, double–blind, placebo–controlled study. JPEN J Parenter Enteral Nutr. 2000;24:133–139.

16. Shabert JK, Winslow C, Lacey JM, Wilmore DW. Glutamine–antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double–blind controlled trial. Nutrition. 1999;15:860–864.

17. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations [between] HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis. 2003;37(suppl 2):S69–S80.

18. Gerrior JL, Neff LM. Nutrition assessment in HIV infection. Nutr Clin Care. 2005;8:6–15.

19. Calza L, Manfredi R, Chiodo F. Dyslipidaemia associated with antiretroviral therapy in HIV–infected patients. J Antimicrob Chemother. 2004;53:10–14.

20. Winkler P, Ellinger S, Boetzer AM, et al. Lymphocyte proliferation and apoptosis in HIV–seropositive and healthy subjects during long–term ingestion of fruit juices or a fruit–vegetable–concentrate rich in polyphenols and antioxidant vitamins. Eur J Clin Nutr. 2004;58:317–325.

21. Gil L, Lewis L, Martinez G, et al. Effect of increase of dietary micronutrient intake on oxidative stress indicators in HIV/AIDS patients. Int J Vitam Nutr Res. 2005;75:19–27.

22. Tang AM, Lanzillotti J,  Hendricks K et al.  Micronutrients: current issues for HIV care providers. AIDS. 2005;19:847–861.

23. Lanzillotti JS, Tang AM. Micronutrients and HIV disease: a review pre– and post–HAART. Nutr Clin Care. 2005;8:16–23.

24. Irlam JH, Visser ME, Rollins N, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev. 2005;(4):CD003650.

25. Burbano X, Miguez–Burbano MJ, McCollister K, et al. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV–infected participants. HIV Clin Trials. 2002;3:483–491.

26. Singhal N, Austin J. A clinical review of micronutrients in HIV infection. J Int Assoc Physicians AIDS Care (Chicago, Ill). 2002;1:63–75.

27. Huycke MM, Naguib MT, Stroemmel MM, et al. A double–blind placebo–controlled crossover trial of intravenous magnesium sulfate for foscarnet–induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection. Antimicrob Agents Chemother. 2000;44:2143–2148.